Straumann Holding AG (SAUHY)
Straumann Holding AG operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Basel, BS, CH. The stock last traded at $12.61, down 1.46% on the session, giving a market capitalisation of $20.11B. On trailing twelve-month figures it carries a trailing P/E of 45.67, a net margin of 13.7%. Its beta of 1.38 implies it has historically moved more than the broad market.
Straumann Holding AG is a leading global provider of comprehensive dental solutions, specializing in tooth restoration, replacement, and orthodontic treatment. The company actively engages in the research, development, production, and distribution of a diverse portfolio of dental products. This range encompasses advanced dental implants, precision instruments, CAD/CAM prosthetics, clear orthodontic aligners, biomaterials, and cutting-edge digital technologies. These offerings are designed to facilitate tooth correction, replacement, and restoration, while also playing a role in preventing future tooth loss. Straumann's core product lines include a wide array of dental implant systems, featuring tissue and bone level options crafted from materials like titanium, titanium alloy, and ceramics, alongside specialized mini-implants. The company also supplies a full suite of surgical instruments, both guided and non-guided, vital for implant procedures, as well as various implant-supported prosthetics. It excels in digital dentistry, offering sophisticated intraoral scanning solutions, 3D printers, and milling machines. Complementing these are ceramic healing and screw-retained abutments, and a selection of preventative oral care products. A significant part of its portfolio is dedicated to biomaterials, including bone substitutes, specialized membranes, biologics, and products for soft tissue management and enhanced oral healing. Digital solutions extend to dental laboratories, clinics, and central milling facilities, supported by a range of materials, third-party system integrations, and guided surgery technologies. Its comprehensive surgical instrument catalog features modular and specialized cassettes, implant maintenance tools, bone block fixation sets, bonerings, and titanium pin sets. For patients with complete tooth loss (edentulous patients), Straumann provides specialized solutions like pro arch fixed prosthetics and mini implant systems. The company also focuses on aesthetic restorations, offering ceramic implant monotypes, ceramic implants, and various abutments, often enhanced by biologics. Its offerings further include the Clear Correct aligner system for orthodontic correction, and Emdogain, a product designed for wound healing. Beyond products, Straumann is committed to professional development, providing extensive training and educational services to its client base. Straumann's diverse clientele includes general dentists, dental specialists, and technicians working in laboratories. It also serves corporate entities such as distributors, hospitals, universities, and large dental service organizations. Its products reach customers in approximately 100 countries, facilitated by a robust network of direct distribution subsidiaries and strategic partners. Established in 1954, Straumann Holding AG maintains its corporate headquarters in Basel, Switzerland.
Straumann Holding AG is most often compared with the following Healthcare names: